Skip to main content
SpringerLink
Log in

Arrhythmias in patients with heart failure

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Both atrial and ventricular arrhythmias are very common in patients with congestive heart failure, and their presence is associated with symptoms, significant morbidity, and mortality. Studies have attempted to determine the prognostic significance of atrial and ventricular arrhythmias in patients with heart failure. Whether atrial fibrillation is an independent risk factor of mortality remains controversial. The presence of ventricular arrhythmias in patients with ischemic cardiomyopathy identifies patients at high risk for sudden death. However, in patients with nonischemic cardiomyopathy there is not a strong correlation between ventricular arrhythmias and increased risk for sudden death. Multiple trials using antiarrhythmic drugs, pharmacologic therapy, and implantable cardioverter defibrillators have been performed in an attempt to improve survival in patients 1) post-myocardial infarction; 2) with congestive heart failure, with and without nonsustained ventricular tachycardia; and 3) with sustained ventricular tachycardia and those who have survived an out-of-hospital cardiac arrest. The purpose of this article is to present an overview of arrhythmias in patients with heart failure and discuss the prevalence, prognostic significance, complications, mechanisms, and trials that have formed the current therapies presently used.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Greene HL: Clinical significance and management of arrhythmias in the heart failure patient. Clin Cardiol 1992, 15(suppl 1):I13–121.

    PubMed  Google Scholar 

  2. Francis GS: Development of arrhythmias in the the patient with congestive heart failure: Pathophysiology, prevalence and prognosis. AM J Cardiol 1986, 57:3B-7B.

    Article  PubMed  CAS  Google Scholar 

  3. Smith WM: Epidemiology of congestive heart failure. Am J Cardiol 1985, 55:3A-8A.

    Article  PubMed  CAS  Google Scholar 

  4. Parmley WW: Pathophysiology and current therapy of congestive heart failure. J Am Coll Cardiol 1989, 13:771–785.

    Article  PubMed  CAS  Google Scholar 

  5. Graves EG, Gillum BS: 1994 Summary: National Hospital Discharge Survey: Advance Data. Hyattsville, MD:National Center for Health Statistics; 1996:278:1.

    Google Scholar 

  6. Levy D, Larson GM, Vasan RS, et al.: Temporal trends in mortality following the onset of heart failure in subjects from the Framingham Heart Study [abstract]. Circulation 2000, 102:II-412.

    Google Scholar 

  7. McKee PA, Castelli WP, McNamara M, Kannel WB: The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971, 285:1141–1146.

    Article  Google Scholar 

  8. Kopecky SL, Gersh BJ, McGoon MD, et al.: The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 1987, 317:669–674.

    Article  PubMed  CAS  Google Scholar 

  9. Pozzoli M, Cioffi G, Traversi E, et al.: Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 1998, 32:197–204. A prospective study showing only impaired left atrial contraction and reversible atrial fibrillation predicts the development of chronic atrial fibrillation in patients with HF.

    Article  PubMed  CAS  Google Scholar 

  10. Middlekauff HR, Stevenson WG, Stevenson LW: Prognostic significance of atrial fibrillation in advanced heart failure: a study of 390 patients. Circulation 1991, 84:40–48.

    PubMed  CAS  Google Scholar 

  11. Carson PE, Johnson GR, Dunkman WB, et al.: The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 1993, 87:VI102-VI110.

    PubMed  CAS  Google Scholar 

  12. Stevenson WG, Stevenson LW, Middlekauff HR, et al.: Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 1996, 28:1458–1463.

    Article  PubMed  CAS  Google Scholar 

  13. Dries DL, Exner DV, Gersh BJ, et al.: Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol 1998, 32:695–703. Substudy analysis of the SOLVD trial to determine if atrial fibrillation is an independent predictor of a worse prognosis in patients with HF.

    Article  PubMed  CAS  Google Scholar 

  14. Mahoney P, Kimmel S, DeNofrio D, et al.: Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol 1999, 83:1544–1547. A recent study showing atrial fibrillation is not an independent predictor of increased mortality in HF patients.

    Article  PubMed  CAS  Google Scholar 

  15. Mathew J, Hunsberger S, Fleg J, et al.: Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest 2000, 118:914–922. Showed atrial fibrillation is an independent risk factor for a worse prognosis in patients with HF.

    Article  PubMed  CAS  Google Scholar 

  16. Grogan M, Smith HC, Gersh BJ, Wood DW: Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992, 69:1570–1575.

    Article  PubMed  CAS  Google Scholar 

  17. Heinz G, Siostrzonek P, Kreiner G, et al.: Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol 1992, 69:489–492.

    Article  PubMed  CAS  Google Scholar 

  18. Clark DM, Plumb VJ, Epstein AE, Kay GN: Hemodynamic effects of irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997, 30:1039–1045.

    Article  PubMed  CAS  Google Scholar 

  19. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril survival Study (CONSENSUS). The CONSENSUS Trial Study Group [no authors listed]. N Engl J Med 1987, 316:1429–1435.

  20. Samet P, Berstein W, Levine S: Significance of the atrial contribution to ventricular filling. Am J Cardiol 1965, 15:195–202.

    Article  PubMed  CAS  Google Scholar 

  21. Greenberg B, Chatterjee K, Parmely WW, et al.: The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J 1979, 98:742–751.

    Article  PubMed  CAS  Google Scholar 

  22. Atrial fibrillation follow-up investigation of rhythm management—the AFFIRM study design. The Planning and Steering Committee of the AFFIRM study for the NHLBI AFFIRM investigators [no authors listed]. Am J Cardiol 1997, 79:1198–1202.

  23. Ehrlich JR, Nattel S, Hohnloser SH: Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important disease sets. J Cardiovasc Electrophysiol 2002, 13:399–405. Excellent recent review of atrial fibrillation and HF. Authors address both pharmacologic and nonpharmacologic therapies for atrial fibrillation.

    Article  PubMed  Google Scholar 

  24. Preliminary report: effect of ecainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators [no authors listed]. N Engl J Med 1989, 321:406–412.

  25. Flaker GC, Blackshear JL, McBride R, et al.: Antiarhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992, 20:527–532.

    Article  PubMed  CAS  Google Scholar 

  26. Falk RH: Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 1992, 117:141–150.

    PubMed  CAS  Google Scholar 

  27. Doval HC, Nul DR, Grancelli HO, et al.: Randomized trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994, 344:493–498.

    Article  PubMed  CAS  Google Scholar 

  28. Singh SN, Fletcher RD, Fisher SG, et al.: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995, 333:77–82.

    Article  PubMed  CAS  Google Scholar 

  29. Deedwania PC, Singh BN, Ellenbogen K, et al.: Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation 1998, 98:2574. Prospective study demonstrating that amiodarone does not improve survival in HF predominantly consisting of ischemic cardiomyopathy patients. A trend toward improved survival was seen in nonischemic cardiomyopathy patients.

    PubMed  CAS  Google Scholar 

  30. Torp-Pederson C, Moller M, Bloch-Thomsen PE, et al.: Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 1999, 341:857–865. Study demonstrating that dofetilide has no adverse effects on survival of patients with HF.

    Article  Google Scholar 

  31. Fuster V, Rydèn LE, Asinger RW, et al.: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2001, 38:1231–1265. ACC/AHA guidelines of indications for therapy in patients with atrial fibrillation.

    Article  PubMed  CAS  Google Scholar 

  32. Podrid PJ: Management of ventricular arrhythmias. In Congestive Heart Failure. Edited by Hosenpud JD, Greenberg BH. Philadelphia: Lippincot Williams & Wilkins; 2000:725–742.

    Google Scholar 

  33. Khoshnevis GR, Massumi A: Ventricular arrhythmias in congestive heart failure: clinical significance and management. Tex Heart Inst J 1999, 26:42–59. An excellent review of ventricular arrhythmias in HF.

    PubMed  CAS  Google Scholar 

  34. Bigger JT, Fleiss JL, Kleiger R, et al.: The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984, 69:250–258.

    PubMed  Google Scholar 

  35. Mukharji J, Rude RE, Poole WK, et al.: Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am J Cardiol 1984, 54:31–36.

    Article  PubMed  CAS  Google Scholar 

  36. Gilmour RF: Enhanced automaticity. In Cardiac Arrhythmia: Mechanisms, Diagnosis and Management. Edited by Podrid PJ, Kowey PR. Baltimore, MD:Williams & Wilkins; 1995:78–87.

    Google Scholar 

  37. Cranefield PF, Aronson RS: Cardiac Arrhythmias: The Role of Triggered Activity and Other Mechanisms. Mount Kisco, NY: Futura Publishing Company; 1988.

    Google Scholar 

  38. Morganroth J, Bigger JT: Pharmacologic management of ventricular arrhythmias after cardiac arrhythmia suppression trial. Am J Cardiol 1990, 65:1497–1503.

    Article  PubMed  CAS  Google Scholar 

  39. Buxton AE, Hafley GE, Lehmann MH, et al.: Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease utility of clinical variables, for the Multicenter Unsustained Tachycardia Trial (MUSTT). Circulation 1999, 99:1843–1850. A prospective trial showing the limited ability of baseline clinical variables to guide clinical decisions regarding the use of electrophysiologic testing for risk stratification.

    PubMed  CAS  Google Scholar 

  40. Singh SN, Fletcher RD, Fisher SG, et al.: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995, 333:77–82.

    Article  PubMed  CAS  Google Scholar 

  41. Actuarial risk of sudden death while awaiting cardiac transplantation in patients with atherosclerotic heart disease. Am DEFIBRILLAT Study Group [no authors listed]. J Cardiol 1991, 68:545–546.

  42. Kjekshus J: Arrhythmias and mortality in congestive heart failure. Am J Cardiol 1990, 65:42I-48I.

    Article  PubMed  CAS  Google Scholar 

  43. Packer M: Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation 1992, 85:50I-56I.

    Google Scholar 

  44. Flaker GC, Blackshear JL, McBride R, et al.: Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. J Am Coll Cardiol 1992, 20:527–532.

    Article  PubMed  CAS  Google Scholar 

  45. Echt DS, Liebson PR, Mitchell LB, et al.: Mortality and morbidity in patients receiving ecainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991, 324:781–788.

    Article  PubMed  CAS  Google Scholar 

  46. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II Investigators [no authors listed]. N Engl J Med 1992, 327:227–233.

  47. Naccarelli GV, Dougherty AH, Jalal S, et al.: Cardiac Arrhythmia Suppression Trial (CAST): interpretation of the findings and effect on drug development and prescribing practices. Hosp Formul 1992, 27:792–805.

    Google Scholar 

  48. Siebels J, Cappato R, Ruppel R, et al.: Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators. Am J Cardiol 1993, 72:109F-113F.

    Article  PubMed  CAS  Google Scholar 

  49. Packer M, Bristow MR, Cohn JN, et al.: The effect of carvedilol on morbidity in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996, 334:1349–1355.

    Article  PubMed  CAS  Google Scholar 

  50. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial [no authors listed]. Lancet 1999, 353:9–13. Demonstrated that bisoprolol improves survival and decreases sudden death in CHF patients.

  51. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) [no authors listed]. Lancet 1999, 353:2001–2007. Demonstrated that long-acting metoprolol improves survival and decreases sudden death in CHF patients.

  52. Julian DG, Camm AJ, Fraglin G, et al.: Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997, 349:667–674.

    Article  PubMed  CAS  Google Scholar 

  53. Cairns JA, Connolly SJ, Roberts R, et al.: Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997, 349:675–682.

    Article  PubMed  CAS  Google Scholar 

  54. Sim I, McDonald KM, Lavori PW, et al.: Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death. Circulation 1997, 96:2823–2829.

    PubMed  CAS  Google Scholar 

  55. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomized trials. Amiodarone Trials Meta-Analysis Investigators [no authors listed]. Lancet 1997, 350:1417–1424.

  56. Wilber DJ, Kall JG, Kapp DE: What can we expect from prophylactic implantable defibrillators? Am J Cardiol 1997, 80:20F-27F.

    Article  PubMed  CAS  Google Scholar 

  57. Camm AJ, Karam R, Pratt C: The azimilide post-infarct survival evaluation (ALIVE) trial. Am J Cardiol 1998, 81:35D-39D.

    Article  PubMed  CAS  Google Scholar 

  58. Bigger JT: Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 1997, 337:1569–1575.

    Article  PubMed  Google Scholar 

  59. Moss AJ, Hall WJ, Cannom DS, et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996, 335:1993–1940.

    Article  Google Scholar 

  60. Buxton AE, Lee KL, DiCarlo L, et al.: Nonsustained ventricular tachycardia in coronary artery disease: relation to inducible sustained ventricular tachycardia. Multicenter Unsustained Tachycardia Trial (MUSTT) Investigators. Ann Intern Med 1996, 125:35–39.

    PubMed  CAS  Google Scholar 

  61. Moss AJ, Zareba W, Hall J, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. Multicenter Automatic Defibrillator Implantation Trial II Investigators. N Engl J Med 2002, 346:877–883. This trial demonstrates post-MI patients with LV dysfunction have improved survival after the implantation of an ICD versus antiarrhythmic drugs.

    Article  PubMed  Google Scholar 

  62. Anderson JL, Hallstrom AP, Epstein AE, et al.: Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators. Circulation 1999, 99:1692–1699. Study demonstrating that ICD therapy is more beneficial than amiodarone in sustained VT and VF patients with ejection fractions less than 35%.

    PubMed  CAS  Google Scholar 

  63. Connolly SJ, Gent M, Roberts RS, et al.: Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators. Am J Cardiol 1993, 72:103F-108F.

    Article  PubMed  CAS  Google Scholar 

  64. Cappato R: Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study. Am J Cardiol 1999, 83:68D-73D. Review of secondary prevention ICD trials.

    Article  PubMed  CAS  Google Scholar 

  65. Naccarelli GV, Wolbrette DL, Dell’Orfano JT, et al.: A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: From CAST to AVID and beyond. J Cardiovasc Electrophysiol 1998, 9:864–891. Excellent review of the major trials using antiarrhythmic drugs, pharmacologic therapy, and ICD therapy that have been performed in an attempt to improve survival in patients 1) post-MI; 2) with HF, with and without NSVT; and 3) with sustained VT and those who have survived an out-of-hospital cardiac arrest.

    Article  PubMed  CAS  Google Scholar 

  66. Gregoratos G, Cheitlin MD, Conill A, et al.: ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmic devices: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implatation). J Am Coll Cardiol 1998, 31:1175–1209.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Penn State University College of Medicine, M.C. H047, 17033, Hershey, PA, USA

    B. John Hynes MD, Jerry C. Luck MD, Deborah L. Wolbrette MD, John Boehmer MD & Gerald V. Naccarelli MD

Authors
  1. B. John Hynes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jerry C. Luck MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Deborah L. Wolbrette MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John Boehmer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gerald V. Naccarelli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hynes, B.J., Luck, J.C., Wolbrette, D.L. et al. Arrhythmias in patients with heart failure. Curr Treat Options Cardio Med 4, 467–485 (2002). https://doi.org/10.1007/s11936-002-0041-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-002-0041-1

Keywords

Search

Navigation